Fellow of The Academy of Medical Sciences, United Kingdom
His scientific interests lie mostly in Immunology, Internal medicine, Transplantation, Chronic lymphocytic leukemia and Leukemia. His study in Immunology concentrates on Antigen, Immune system, CD28, T cell and Lymphoma. His Antigen study combines topics in areas such as Immunotherapy and Antigen-presenting cell.
John G. Gribben interconnects Gastroenterology, Surgery and Oncology in the investigation of issues within Internal medicine. The Transplantation study combines topics in areas such as Stem cell and Bone marrow. His research in Chronic lymphocytic leukemia intersects with topics in Hematopoietic stem cell transplantation, Disease, Clinical trial and Antibody.
John G. Gribben mainly focuses on Internal medicine, Immunology, Chronic lymphocytic leukemia, Cancer research and Oncology. John G. Gribben has researched Internal medicine in several fields, including Gastroenterology and Surgery. His Immunology research focuses on Cytotoxic T cell and how it connects with CD8.
His work deals with themes such as Antibody and Fludarabine, which intersect with Chronic lymphocytic leukemia. He combines subjects such as Cancer, Signal transduction, Apoptosis and Diffuse large B-cell lymphoma with his study of Cancer research. His Oncology study incorporates themes from Relapsed refractory, Clinical trial, Disease and Chemotherapy.
His primary areas of study are Internal medicine, Cancer research, Oncology, Chronic lymphocytic leukemia and Ibrutinib. The concepts of his Cancer research study are interwoven with issues in Cytokine, Leukemia, Flow cytometry and Diffuse large B-cell lymphoma. His Oncology study integrates concerns from other disciplines, such as Hematopoietic stem cell transplantation and Transplantation.
His study in Transplantation is interdisciplinary in nature, drawing from both Human leukocyte antigen, Multiple myeloma and Clinical trial. His Chronic lymphocytic leukemia study is concerned with the field of Immunology as a whole. He is interested in Immune system, which is a field of Immunology.
John G. Gribben focuses on Internal medicine, Cancer research, Oncology, Disease and Ibrutinib. His Cancer research research includes elements of Tumor progression, Leukemia, Malignancy and Bone marrow. His Oncology research is multidisciplinary, relying on both Chlorambucil, Hematopoietic stem cell transplantation, Diffuse large B-cell lymphoma, Pathology and Histocompatibility Testing.
The various areas that John G. Gribben examines in his Disease study include Cancer, Lymphocytic leukaemia, Adverse effect, Immune system and Autologous stem-cell transplantation. His Chronic lymphocytic leukemia study is concerned with the larger field of Immunology. His studies deal with areas such as Transcriptome and Somatic evolution in cancer as well as Immunology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Cloning of B7-2: A CTLA-4 counter-receptor that costimulates human T cell proliferation
Gordon J. Freeman;John G. Gribben;Vassiliki A. Boussiotis;Judy W. Ng.
ZAP-70 Compared with Immunoglobulin Heavy-Chain Gene Mutation Status as a Predictor of Disease Progression in Chronic Lymphocytic Leukemia
Laura Z. Rassenti;Lang Huynh;Tracy L. Toy;Liguang Chen.
The New England Journal of Medicine (2004)
Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma.
John G. Gribben;Arnold S. Freedman;Donna Neuberg;Denis C. Roy.
The New England Journal of Medicine (1991)
Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation.
Claude D. Gimmi;Gordon J. Freeman;John G. Gribben;Gary Gray.
Proceedings of the National Academy of Sciences of the United States of America (1993)
Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug
Alan G. Ramsay;Amy J. Johnson;Abigail M. Lee;Güllü Gorgün.
Journal of Clinical Investigation (2008)
B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2.
Claude D. Gimmi;Gordon J. Freeman;John G. Gribben;Kanji Sugita.
Proceedings of the National Academy of Sciences of the United States of America (1991)
Transplantation of anergic histoincompatible bone marrow allografts.
Eva C. Guinan;Vassiliki A. Boussiotis;Donna Neuberg;Lisa LaVita Brennan.
The New England Journal of Medicine (1999)
Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma
Jessica Okosun;Csaba Bödör;Jun Wang;Shamzah Araf.
Nature Genetics (2014)
All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment.
John G. Gribben;Arnold S. Freedman;Sunhee D. Woo;Kelly Blake.
Rituximab and CHOP Induction Therapy for Newly Diagnosed Mantle-Cell Lymphoma: Molecular Complete Responses Are Not Predictive of Progression-Free Survival
Orion M. Howard;John G. Gribben;Donna S. Neuberg;Michael Grossbard.
Journal of Clinical Oncology (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: